Disclosure Of Cash Flow Statement [Text Block]

Zealand Pharma - Filing #1382971

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2019-12-31
Disclosure of cash flow statement [text block]
Description of accounting policy for determining components of cash and cash equivalents [text block]
Cash and cash equivalents if different from statement of financial position [abstract]
Cash and cash equivalents
1,069,234,000 EUR
1,129,103,000 EUR
960,221,000 EUR
1,081,060,000 EUR
Income taxes paid (refund) [abstract]
Income taxes paid (refund), classified as operating activities
9,277,000 EUR
41,631,000 EUR
0 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.